Skip to content

The impact of BD InstaFlash™ Needle Technology in Venflon™ Pro Safety needles on first attempt success rate of peripheral intravenous cannulation in adult patients, a double-blinded and randomized controlled trial

INSTAFLASH study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON20431
Enrollment
660
Registered
2019-05-21
Start date
2019-07-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Indication for peripheral intravenous cannulation, regardless the medical specialism or type of surgery they are admitted for.

Interventions

A peripheral intravenous catheter is a small hollow catheter that is advanced over a needle into a peripheral vein through the skin. There are four consecutive stages for peripheral intravenous cannul

Sponsors

Catharina Ziekenhuis
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: In order to be eligible to participate in this study, a subject must meet all of the following criteria: subjects must be in the age of 18 years or older; subjects must be conscious and be able to adequately answer questions.

Exclusion criteria

Exclusion criteria: A potential subject who meets any of the following criteria will be excluded from participation in this study: when an intravenous catheter is already inserted on the ward; are unwilling or unable to provide consent to participate; do not understand questions or generate adequate data, due to physical or communicational disorders.

Design outcomes

Primary

MeasureTime frame
The primary objective is stated as the first attempt success rate of peripheral intravenous cannulation.

Secondary

MeasureTime frame
As secondary objectives, we are interested in the effects of the Venflon™ (Pro Safety with or without the BD InstaFlash™ Needle Technology) on the time needed for intravenous cannulation, the total number of attempts needed for successful cannulation, patients and practitioners satisfaction, pain score upon intravenous cannulation, practitioners satisfaction, and complications or side effects.

Contacts

Public ContactFredericus HJ van Loon

Catharina Ziekenhuis

rick.v.loon@catharinaziekenhuis.nl0031402399111

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)